SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000513
Filing Date
2021-04-19
Accepted
2021-04-19 17:10:20
Documents
13
Period of Report
2021-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620493_8k-immunic.htm   iXBRL 8-K 22096
2 e620493_ex10-1.htm EX-10.1 7578
  Complete submission text file 0001193805-21-000513.txt   206375

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imux-20210415.xsd EX-101.SCH 3059
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20210415_lab.xml EX-101.LAB 34238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20210415_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT e620493_8k-immunic_htm.xml XML 3695
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 21835373
SIC: 2834 Pharmaceutical Preparations